Migraine & Women's Health (AHS & Pfizer) - Headache & Migraine Competitive Grant Program

About this program

The American Headache Society, in collaboration with Pfizer, is offering the Headache & Migraine Competitive Grant Program to support innovative quality-improvement and research projects that develop scalable tools and measurable improvements in headache and migraine care, including a dedicated migraine and women's health track. Individual awards typically fund up to $200,000–$250,000 total over two years and prioritize adult-focused, patient-centered, equity-minded interventions implemented in primary care or non-headache specialty settings. Applicants must submit a Letter of Intent (only accepted LOIs are invited to submit full proposals) and are expected to be collaborative multidisciplinary teams proposing projects with clear quality-improvement aims, measurable outcomes, and potential for broad real-world adoption.